Literature DB >> 29445525

Physiological consequences of CPAP therapy withdrawal in patients with obstructive sleep apnoea-an opportunity for an efficient experimental model.

Esther I Schwarz1, John R Stradling2, Malcolm Kohler1,3.   

Abstract

Randomised controlled trials (RCTs) of continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA) are time consuming, and their findings often inconclusive or limited due to suboptimal CPAP adherence in CPAP-naïve patients with OSA. Short-term CPAP withdrawal in patients with prior optimal CPAP adherence results in recurrence of OSA and its consequences. Thus, this experimental model serves as an efficient tool to investigate both the consequences of untreated OSA, and potential treatment alternatives to CPAP. The CPAP withdrawal protocol has been thoroughly validated, and applied in several RCTs focusing on cardiovascular and metabolic consequences of untreated OSA, as well as the assessment of treatment alternatives to CPAP.

Entities:  

Keywords:  Obstructive sleep apnoea (OSA); continuous positive airway pressure (CPAP); pathophysiology; randomised controlled trial

Year:  2018        PMID: 29445525      PMCID: PMC5803046          DOI: 10.21037/jtd.2017.12.142

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  47 in total

1.  Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome.

Authors:  P M Turkington; M Sircar; D Saralaya; M W Elliott
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

2.  Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study.

Authors:  Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

3.  Effects of continuous positive airway pressure treatment and withdrawal in patients with obstructive sleep apnea on arterial stiffness and central BP.

Authors:  Craig L Phillips; Brendon Yee; Qiao Yang; Anna Tessa Villaneuva; Jan Hedner; Norbert Berend; Ronald Grunstein
Journal:  Chest       Date:  2008-03-17       Impact factor: 9.410

4.  Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis.

Authors:  Sanjay R Patel; David P White; Atul Malhotra; Michael L Stanchina; Najib T Ayas
Journal:  Arch Intern Med       Date:  2003-03-10

5.  Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial.

Authors:  C Jenkinson; R J Davies; R Mullins; J R Stradling
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

6.  Obstructive Sleep Apnea Dynamically Increases Nocturnal Plasma Free Fatty Acids, Glucose, and Cortisol During Sleep.

Authors:  Swati Chopra; Aman Rathore; Haris Younas; Luu V Pham; Chenjuan Gu; Aleksandra Beselman; Il-Young Kim; Robert R Wolfe; Jamie Perin; Vsevolod Y Polotsky; Jonathan C Jun
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

7.  Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares.

Authors:  C E Sullivan; F G Issa; M Berthon-Jones; L Eves
Journal:  Lancet       Date:  1981-04-18       Impact factor: 79.321

8.  The effect of modafinil following acute CPAP withdrawal: a preliminary study.

Authors:  Shaun C Williams; Naomi L Rogers; Nathaniel S Marshall; Stefanie Leung; Graham A Starmer; Ronald R Grunstein
Journal:  Sleep Breath       Date:  2008-03-01       Impact factor: 2.816

9.  Withdrawal of Continuous Positive Airway Pressure Therapy for 2 Weeks in Obstructive Sleep Apnoea Patients Results in Increased Circulating Platelet and Leucocyte-Derived Microvesicles.

Authors:  Lisa Ayers; Chris Turnbull; Nayia Petousi; Berne Ferry; Malcolm Kohler; John Stradling
Journal:  Respiration       Date:  2016-05-12       Impact factor: 3.580

10.  Significant improvement of olfactory performance in sleep apnea patients after three months of nasal CPAP therapy - Observational study and randomized trial.

Authors:  Bettina Boerner; Gabrielo M Tini; Patrick Fachinger; Sereina M Graber; Sarosh Irani
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

View more
  4 in total

1.  Reperfusion injury to ischemic medullary brain nuclei after stopping continuous positive airway pressure-induced CO2-reduced vasoconstriction in sleep apnea.

Authors:  J Howard Jaster
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Sleep-disordered breathing and cerebral small vessel disease-acute and 6 months after ischemic stroke.

Authors:  Sofie Amalie Simonsen; Adam Vittrup Andersen; Anders Sode West; Frauke Wolfram; Poul Jennum; Helle K Iversen
Journal:  Sleep Breath       Date:  2021-09-02       Impact factor: 2.655

3.  Socioeconomic status impacts blood pressure response to positive airway pressure treatment.

Authors:  Ikuyo Imayama; Ahana Gupta; Pei-Shan Yen; Yi-Fan Chen; Brendan Keenan; Raymond R Townsend; Julio A Chirinos; Frances M Weaver; David W Carley; Samuel T Kuna; Bharati Prasad
Journal:  J Clin Sleep Med       Date:  2022-05-01       Impact factor: 4.324

4.  A Novel Model to Estimate Key Obstructive Sleep Apnea Endotypes from Standard Polysomnography and Clinical Data and Their Contribution to Obstructive Sleep Apnea Severity.

Authors:  Ritaban Dutta; Gary Delaney; Barbara Toson; Amy S Jordan; David P White; Andrew Wellman; Danny J Eckert
Journal:  Ann Am Thorac Soc       Date:  2021-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.